Research Finds Potential Cancer Risk Marker in Chinese Population
A new study published in the journal Nucleosides, Nucleotides & Nucleic Acids has made a significant discovery in the field of biotechnology-bioinformatics. Researchers from the School of Pharmacy, Yancheng Teachers' University, have identified a potential cancer risk marker in the Chinese population, which could lead to improved diagnosis and treatment of certain cancers. The study, led by Jinyin Xue, focused on the relationship between gene polymorphisms and cancer susceptibility.
Key Takeaways:
- The research found that the rs34787247 G A polymorphism was associated with cancer susceptibility in the Chinese population, with an Odd Ratio (OR) of 1.98 and 95% Confidence Interval (CI) of 1.35-2.89.
- The meta-analysis and data mining were completed using STATA software and the GSCA platform, respectively.
- The study concluded that the rs34787247 G A polymorphism might be used as a cancer risk marker in the Chinese population.
- LIN28A was identified as a prognostic marker and therapeutic target for certain cancers.
- The study's findings highlight the importance of further research into the relationship between gene polymorphisms and cancer susceptibility.
Statistics:
- 1.98: the Odd Ratio (OR) for cancer susceptibility associated with the rs34787247 G A polymorphism.
- 1.35-2.89: the 95% Confidence Interval (CI) for the Odd Ratio (OR).
- 44(8): the issue and page numbers of the journal Nucleosides, Nucleotides & Nucleic Acids where the study was published.
- 643-652: the page numbers of the study in the journal Nucleosides, Nucleotides & Nucleic Acids.
Sources:
- Clinical significance of LIN28A gene polymorphisms and expression in pan-cancer: a meta-analysis and bioinformatic analysis. Nucleosides, Nucleotides & Nucleic Acids, 2024;44(8):643-652.
- NewsRx. School of Pharmacy Reports Findings in Bioinformatics (Clinical significance of LIN28A gene polymorphisms and expression in pan-cancer: a meta-analysis and bioinformatic analysis). China Weekly News. July 8, 2025; p 646.